Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels.
Open Access
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 260 (27) , 14621-14625
- https://doi.org/10.1016/s0021-9258(17)38613-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Intima-related vasodilatation of the perfused rat caudal arteryEuropean Journal of Pharmacology, 1984
- 9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activitiesBiochemical and Biophysical Research Communications, 1982
- Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compoundsNature, 1981
- Purification and partial characterization of prostaglandin D2 11-keto reductase in rabbit liverBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- Enzymatic formation of prostaglandin D2 by rat basophilic leukemia cells and normal rat mast cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Hepatic metabolism of prostacyclin (PGI2) in the rabbit: Formation of a potent novel inhibitor of platelet aggregationBiochemical and Biophysical Research Communications, 1980
- Cellular Mechanisms of Prostaglandin ActionAnnual Review of Physiology, 1979
- Urinary prostaglandins. Identification and origin.Journal of Clinical Investigation, 1975
- Biosynthesis and chemistry of 9α, 15(S)-dihydroxy-11-oxo-13-trans-prostenoic acidBiochemistry, 1972
- N-Butylboronate derivatives of the F prostaglandins : Resolution of prostaglandins of the E and F series by gas—liquid chromatographyJournal of Chromatography A, 1971